ETF PRO AIOctober 8, 2026
PBE Invesco Dynamic Biotechnology & Genome ETF
Fund tearsheet · data as of the latest session · October 8, 2026
ONE YEAR OF DAILY CLOSES
0.58%expense ratio
$423Mfund assets
+15.4%return, YTD
+31.8%return, 1 year
+$930Knet flow, 1 month
+$113Mnet flow, 1 year
19.1%realized volatility, 1y
-11.8%worst drawdown, 1y
Top ten holdings
| 1 | ILMN ILLUMINA | 6.63% |
| 2 | NTRA NATERA | 6.42% |
| 3 | BIIB BIOGEN | 5.15% |
| 4 | GILD GILEAD SCIENCES | 4.94% |
| 5 | AMGN AMGEN | 4.63% |
| 6 | VRTX VERTEX PHARMACEUTICALS | 4.63% |
| 7 | RPRX ROYALTY PHARMA | 4.64% |
| 8 | REGN REGENERON PHARMACEUTICALS | 4.43% |
| 9 | MRNA MODERNA | 3.55% |
| 10 | NVAX NOVAVAX | 3.69% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS